Zsolt Illes

25PUBLICATIONS
67CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyRegenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Oct 05, 2026
Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.

|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|Mar 28, 2026
[Developing anti-CD20 molecules and B cell depletion in multiple sclerosis].

Zsolt Illés

|Aug 29, 2025
Phenotypic Changes in a Monocyte Cluster with High Interleukin-1 Beta Expression during Long-Term Anti-CD20 Therapy.

Mie Waede, Christina Kingo, Karina Damsbo

|Dec 23, 2024
Patterns and predictors of multiple sclerosis phenotype transition.

Luigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm

|Sep 16, 2024
Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy.

Mie Waede, Lasse F Voss, Christina Kingo

Pageof 5

Frequent Collaborators

5 joint publications

Tobias Sejbaek

5 joint publications

Melinda Magyari

3 joint publications

Maria L Elkjaer

3 joint publications

Finn Sellebjerg